Search
Search Results
##search.searchResults.foundPlural##
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4166PDF: 1142HTML: 3921Untitled: 205Cneo. Fig.1: 147Untitled: 138Untitled: 173Untitled: 175 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2724PDF: 925HTML: 9077Efremov 1: 279Efremov 2: 250 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3651PDF: 1496HTML: 2747 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3320PDF: 972HTML: 7327Kost Fig1: 233Kost Fig 2: 220Kost Fig3: 236Kost Fig 4: 246Kost Fig5: 244Kost fig 6: 232 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3573PDF: 1671HTML: 4098 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2419PDF: 960HTML: 2034Fig 1 Rossi: 250 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1542PDF: 880HTML: 1043 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2579PDF: 1297HTML: 3921 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2757PDF: 958HTML: 17624Fig1 Caligaris: 243Fig.2 Caliga: 277 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3082PDF: 1366HTML: 2853Figure 1: 226 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3957PDF: 1745HTML: 115 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1772PDF: 710HTML: 2457 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2519PDF: 1409HTML: 17241Bassan Fig.1: 188Bassan Fig.2: 292Bassan Fig.4: 176Fig.3: 310 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4812PDF: 3964HTML: 383 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4501PDF: 2060HTML: 5570Table 1: 300 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2464PDF: 1091HTML: 7720Untitled: 331Fig2: 232Fig3: 225Fig4: 250 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3500PDF: 993HTML: 1563Fig.1 CHL-R paper: 268Fig 2 CHL-R paper: 311 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2448PDF: 1139HTML: 2041Characteristic of study group: 263 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1773HTML: 721PDF: 933 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3519PDF: 1032HTML: 4982 -
Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study
109PDF: 43Suppl. Files: 15Html: 28Html Suppl. Files: 8 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3973PDF: 1720HTML: 892Figures . Eliassian: 330 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
4020PDF: 1788HTML: 11973Figures Haase: 307 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1653PDF: 1037HTML: 272 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2144PDF: 900HTML: 272







